Review Journal Article Ppublish 10 citations
PubMed: 37948194 DOI: 10.1099/jgv.0.001918
SARS-CoV-2 and the DNA damage response.
J Gen Virol 104(11)
Authors: Roger J Grand
Affiliations
- Institute for Cancer and Genomic Science, The Medical School, University of Birmingham, Birmingham, UK.
Abstract
The recent coronavirus disease 2019 (COVID-19) pandemic was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is characterized by respiratory distress, multiorgan dysfunction and, in some cases, death. The virus is also responsible for post-COVID-19 condition (commonly referred to as 'long COVID'). SARS-CoV-2 is a single-stranded, positive-sense RNA virus with a genome of approximately 30 kb, which encodes 26 proteins. It has been reported to affect multiple pathways in infected cells, resulting, in many cases, in the induction of a 'cytokine storm' and cellular senescence. Perhaps because it is an RNA virus, replicating largely in the cytoplasm, the effect of SARS-Cov-2 on genome stability and DNA damage responses (DDRs) has received relatively little attention. However, it is now becoming clear that the virus causes damage to cellular DNA, as shown by the presence of micronuclei, DNA repair foci and increased comet tails in infected cells. This review considers recent evidence indicating how SARS-CoV-2 causes genome instability, deregulates the cell cycle and targets specific components of DDR pathways. The significance of the virus's ability to cause cellular senescence is also considered, as are the implications of genome instability for patients suffering from long COVID.
MeSH
Cells, Coronavirus, Sars-Cov-2, Cellular Senescence, Genome, Covid-19, Genomic Instability, Viruses, Severe Acute Respiratory Syndrome-Related Coronavirus, Dna Damage
Cited by
- Identification and mechanism analysis of biomarkers related to butyrate metabolism in COVID-19 patients. Ann Med, 2025
- Minimalistic Transcriptomic Signatures Permit Accurate Early Prediction of COVID-19 Mortality. medRxiv, 2025
- Equivocating and Deliberating on the Probability of COVID-19 Infection Serving as a Risk Factor for Lung Cancer and Common Molecular Pathways Serving as a Link. Pathogens, 2025
- Human protein interaction networks of ancestral and variant SARS-CoV-2 in organ-specific cells and bodily fluids. Nat Commun, 2025
- Genetic and Epigenetic Intersections in COVID-19-Associated Cardiovascular Disease: Emerging Insights and Future Directions. Biomedicines, 2025
- Cells that survive acute SARS-CoV-2 infection contribute to inflammation and lung regeneration in mice. mBio, 2025
- P53-Independent G1-Cell Cycle Arrest Increases SARS-CoV-2 RNA Replication. Microorganisms, 2024
- Exploring the Relationship between Telomere Length and Cognitive Changes in Post-COVID-19 Subjects. Biomedicines, 2024